Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 8, 2007, Pages 1233-1237

  Gradman, Josefine ^a   Wolthers, Ole D ^a  

^a Children's Clinic Randers   (Denmark)

Author keywords

Atopic eczema; Growth; Knemometry; Mometasone furoate; Tacrolimus

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; MOMETASONE FUROATE; PROTEIN X; TACROLIMUS;

ANTHROPOMETRY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EOSINOPHIL; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; LEG; MALE; OUTCOME ASSESSMENT; PREPUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADMINISTRATION, TOPICAL; ANTI-ALLERGIC AGENTS; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ECZEMA; FEMALE; GROWTH DISORDERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEG; MALE; PREGNADIENEDIOLS; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547121688     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00363.x     Document Type: Article

References (28)

1. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000 142 : 931 6.
2. Ellis Hon KL, Christy Kam WY, Leung TF, Drian Lam MC, Wong KY, Kenneth Lee KC, et al. Steroid fears in children with eczema. Acta Paediatr 2006 95 : 1451 5.
3. Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol 2005 6 : 65 77.
4. Prakash A, Benfield P. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998 55 : 145 63.
5. Schou AJ, Plomgaard AM, Thomsen K, Wolthers OD. Lower leg growth suppression caused by inhaled glucocorticoids is not accompanied by reduced thickness of the cutis or subcutis. Acta Paediatr 2004 93 : 623 7.
6. Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993 82 : 635 40.
7. Hanifin JM, Rajka G. Diagnostic features of atopic-dermatitis. Acta Derm Venereol 1980 Suppl. 92 : 44 7.
8. Global Strategy for Asthma Management and Prevention. NIH Publication No 02-3659, Issued January, 1995 (updated 2002). Management segment (chapter 7): updated 2005 from the 2004 document. GINA, 2005. Ref. type: report http://www.ginasthma.org.
9. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol 1998 138 : 293 6.
10. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001 10 : 11 8.
11. Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Folster-Holst R, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005 152 : 1282 9.
12. McCaffery M. Choosing a faces pain scale. Nursing 2002 32 : 68.
13. Hermanussen M, Geiger-Benoit K, Burmeister J, Sippell WG. Knemometry in childhood: accuracy and standardization of a new technique of lower leg length measurement. Ann Hum Biol 1988 15 : 1 15.
14. Hermanussen M. The analysis of short-term growth. Horm Res 1998 49 : 53 64.
15. Wolthers OD, Schou AJ. Short-term growth after withdrawal of exogenous glucocorticoids. Horm Res 2005 64 : 116 8.
16. Wolthers OD, Konstantin-Hansen K, Pedersen S, Petersen KE. Knemometry in the assessment of short-term linear growth in a population of healthy school children. Horm Res 1992 37 : 156 9.
17. Valotis A, Neukam K, Elert O, Hogger P. Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate. J Pharm Sci 2004 93 : 1337 50.
18. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung 1998 48 : 956 60.
19. Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004 170 : 960 6.
20. Turpeinen M. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br J Dermatol 1988 118 : 517 22.
21. Harper J, Smith C, Rubins A, Grean A, Jackson K, Zigure S, et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol 2005 124 : 695 9.
22. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005 211 : 174 87.
23. Kristmundsdottir F, David TJ. Growth impairment in children with atopic eczema. J R Soc Med 1987 80 : 9 12.
24. Massarano AA, Hollis S, Devlin J, David TJ. Growth in atopic eczema. Arch Dis Child 1993 68 : 677 9.
25. Heuck C, Ternowitz T, Herlin T, Wolthers OD. Knemometry in children with atopic dermatitis treated with topical glucocorticoids. Pediatr Dermatol 1998 15 : 7 11.
26. McGowan R, Tucker P, Joseph D, Wallace AM, Hughes I, Burrows NP, et al. Short-term growth and bone turnover in children undergoing occlusive steroid ('wet-wrap') dressings for treatment of atopic eczema. J Dermatolog Treat 2003 14 : 149 52.
27. Heuck C, Heickendorff L, Wolthers OD. A randomised controlled trial of short-term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide. Arch Dis Child 2000 83 : 334 9.
28. Kristjansson S, Strannegard IL, Strannegard O, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996 97 : 1179 87.